EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity

Ziyu Guo, Yihuang Liu, Danyao Chen, Yuming Sun, Daishi Li, Yu Meng, Qian Zhou, Furong Zeng, Guangtong Deng iD, Xiang Chen iD

Journal of Translational Internal Medicine · 19.03.2025 · 13 (1) · 10-32

DOI: 10.1515/jtim-2025-0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 19.03.2025. Verfasst von Ziyu Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 309 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the evolving landscape of cancer treatment, the strategic manipulation of regulated cell death (RCD) pathways has emerged as a crucial component of effective anti-tumor immunity. Evidence suggests that tumor cells undergoing RCD can modify the immunogenicity of the tumor microenvironment (TME), potentially enhancing its ability to suppress cancer progression and metastasis. In this review, we first explore the mechanisms of apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis, along with the crosstalk between these cell death modalities. We then discuss how these processes activate antigen-presenting cells, facilitate the cross-priming of CD8+ T cells, and trigger anti-tumor immune responses, highlighting the complex effects of novel forms of tumor cell death on TME and tumor biology. Furthermore, we summarize potential drugs and nanoparticles that can induce or inhibit these emerging RCD pathways and their therapeutic roles in cancer treatment. Finally, we put forward existing challenges and future prospects for targeting RCD in anti-cancer immunity. Overall, this review enhances our understanding of the molecular mechanisms and biological impacts of RCD-based therapies, providing new perspectives and strategies for cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

anticancer immunityapoptosiscuproptosisferroptosisnecroptosispyroptosistumor microenvironment

Autor:innen und Institutionen

  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, Hunan Province, China.
  • Furong Laboratory, Changsha 410008, Hunan Province, China.
  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
  • Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.

ORCID-Profile: Guangtong Deng, Xiang Chen

Zitieren

APA

Guo, Z., Liu, Y., Chen, D., Sun, Y., Li, D., Meng, Y., Zhou, Q., Zeng, F., Deng, G., & Chen, X. (2025). Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity. Journal of Translational Internal Medicine, 13(1), 10-32. https://doi.org/10.1515/jtim-2025-0004

Vancouver

Guo Z, Liu Y, Chen D, Sun Y, Li D, Meng Y, et al. Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity. Journal of Translational Internal Medicine. 2025;13(1):10-32. doi:10.1515/jtim-2025-0004

BibTeX
@article{Guo2025,
  author = {Guo, Ziyu and Liu, Yihuang and Chen, Danyao and Sun, Yuming and Li, Daishi and Meng, Yu and Zhou, Qian and Zeng, Furong and Deng, Guangtong and Chen, Xiang},
  title = {Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity},
  journal = {Journal of Translational Internal Medicine},
  year = {2025},
  volume = {13},
  number = {1},
  pages = {10--32},
  doi = {10.1515/jtim-2025-0004}
}
Kostenlos starten →